View in EDS

Rusfertide for the treatment of iron overload in HFE-related haemochromatosis: an open-label, multicentre, proof-of-concept phase 2 trial.

Saved in:
Bibliographic Details
Title: Rusfertide for the treatment of iron overload in HFE-related haemochromatosis: an open-label, multicentre, proof-of-concept phase 2 trial.
Authors: Kowdley KV; Liver Institute Northwest, Seattle, WA, USA; Elson S Floyd College of Medicine, Washington State University, Seattle, WA, USA. Electronic address: kkowdley@liverinstitutenw.org., Modi NB; Protagonist Therapeutics, Newark, CA, USA., Peltekian K; Division of Digestive Care and Endoscopy, Department of Medicine, Dalhousie University, Halifax, NS, Canada., Vierling JM; Section of Gastroenterology and Hepatology and Division of Abdominal Transplantation, Baylor College of Medicine, Houston, TX, USA., Ferris C; Tryon Medical Partners, Charlotte, NC, USA., Valone FH; Protagonist Therapeutics, Newark, CA, USA., Gupta S; Protagonist Therapeutics, Newark, CA, USA.
Source: The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2023 Dec; Vol. 8 (12), pp. 1118-1128. Date of Electronic Publication: 2023 Oct 17.
Publication Type: Clinical Trial, Phase II; Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101690683 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2468-1253 (Electronic) NLM ISO Abbreviation: Lancet Gastroenterol Hepatol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37863080
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Rusfertide for the treatment of iron overload in HFE-related haemochromatosis: an open-label, multicentre, proof-of-concept phase 2 trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kowdley+KV%22">Kowdley KV</searchLink>; Liver Institute Northwest, Seattle, WA, USA; Elson S Floyd College of Medicine, Washington State University, Seattle, WA, USA. Electronic address: kkowdley@liverinstitutenw.org.<br /><searchLink fieldCode="AU" term="%22Modi+NB%22">Modi NB</searchLink>; Protagonist Therapeutics, Newark, CA, USA.<br /><searchLink fieldCode="AU" term="%22Peltekian+K%22">Peltekian K</searchLink>; Division of Digestive Care and Endoscopy, Department of Medicine, Dalhousie University, Halifax, NS, Canada.<br /><searchLink fieldCode="AU" term="%22Vierling+JM%22">Vierling JM</searchLink>; Section of Gastroenterology and Hepatology and Division of Abdominal Transplantation, Baylor College of Medicine, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Ferris+C%22">Ferris C</searchLink>; Tryon Medical Partners, Charlotte, NC, USA.<br /><searchLink fieldCode="AU" term="%22Valone+FH%22">Valone FH</searchLink>; Protagonist Therapeutics, Newark, CA, USA.<br /><searchLink fieldCode="AU" term="%22Gupta+S%22">Gupta S</searchLink>; Protagonist Therapeutics, Newark, CA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101690683%22">The lancet. Gastroenterology & hepatology</searchLink> [Lancet Gastroenterol Hepatol] 2023 Dec; Vol. 8 (12), pp. 1118-1128. <i>Date of Electronic Publication: </i>2023 Oct 17.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+B%2EV%22">Elsevier B.V </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>101690683 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2468-1253 (Electronic) <i>NLM ISO Abbreviation: </i>Lancet Gastroenterol Hepatol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37863080
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/S2468-1253(23)00250-9
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1118
    Titles:
      – TitleFull: Rusfertide for the treatment of iron overload in HFE-related haemochromatosis: an open-label, multicentre, proof-of-concept phase 2 trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kowdley KV
      – PersonEntity:
          Name:
            NameFull: Modi NB
      – PersonEntity:
          Name:
            NameFull: Peltekian K
      – PersonEntity:
          Name:
            NameFull: Vierling JM
      – PersonEntity:
          Name:
            NameFull: Ferris C
      – PersonEntity:
          Name:
            NameFull: Valone FH
      – PersonEntity:
          Name:
            NameFull: Gupta S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2023 Dec
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2468-1253
          Numbering:
            – Type: volume
              Value: 8
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: The lancet. Gastroenterology & hepatology
              Type: main
ResultId 1